問卷

TPIDB > Principal Investigator

Principal Investigator


Fu Jen Catholic University Hospital

Division of Cardiovascular Diseases

更新時間:2025-08-20

林重佑
  • Principal Investigator
  • Clinical Trial Experience (year)

篩選

List

4Cases

2026-09-01 - 2029-06-30

Phase II

Not yet recruiting
A phase 2, randomized, double-blind, placebo-controlled trial was conducted to evaluate the efficacy, safety, and tolerability of CRD-4730 in patients with heart failure with reduced ejection fraction (HFrEF).
  • Condition/Disease

    Heart failure with reduced ejection fraction

  • Test Drug

    CRD-4730

Participate Sites
4Sites

Not yet recruiting4Sites

2024-10-01 - 2026-12-31

Phase II

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
6Sites

Not yet recruiting6Sites

2024-10-30 - 2026-12-31

Phase II

Completed
-
  • Condition/Disease

    -

  • Test Drug

    -

Participate Sites
6Sites

Recruiting6Sites

2024-02-27 - 2030-01-27

Phase III

Active
  • Condition/Disease

  • Test Drug

Participate Sites
15Sites

Suspended15Sites